Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Kopp Kallner

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Current Opinion in Obstetrics & Gynecology|October 24, 2023
Medical abortion in the second trimester - an updateHelena Kopp Kallner
F1000Research|July 21, 2018
Benefits of reversible contraceptionHelena Kopp Kallner
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 8, 2022
June 24th, 2022: once a right is obtained, it can no longer be lost!Helena Kopp Kallner, Giovanni Grandi
Reproduction & Fertility|April 28, 2026
Post-pregnancy contraceptionMichelle Cooper, Helena Kopp Kallner
Contraception|February 8, 2018
Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usageSara Engstrand, Helena Kopp Kallner
Upsala Journal of Medical Sciences|September 21, 2016
Prevention of unintended pregnancy and use of contraception-important factors for preconception careHelena Kopp Kallner, Kristina Gemzell Danielsson
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 17, 2022
Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case reportFarhad Kafi Mallak, Helena Kopp Kallner
Contraception|December 29, 2020
Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortionAnna Egardt, Michael Algovik, Helena Kopp Kallner
Gynecologic and Obstetric Investigation|March 22, 2019
Urodynamics as a Prognosticator of Mirabegron Treatment OutcomesHelena Kopp Kallner, Caroline Elmér, Daniel Altman
American Journal of Obstetrics and Gynecology|May 25, 2024
Mepivacaine instillation for pain reduction during intrauterine device placement in nulliparous women: a double-blinded randomized trialNiklas Envall, Karin Elgemark, Helena Kopp Kallner
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Obstetrics & Gynecology|October 24, 2023
Medical abortion in the second trimester - an updateHelena Kopp Kallner
F1000Research|July 21, 2018
Benefits of reversible contraceptionHelena Kopp Kallner
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 8, 2022
June 24th, 2022: once a right is obtained, it can no longer be lost!Helena Kopp Kallner, Giovanni Grandi
Reproduction & Fertility|April 28, 2026
Post-pregnancy contraceptionMichelle Cooper, Helena Kopp Kallner
Contraception|February 8, 2018
Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usageSara Engstrand, Helena Kopp Kallner
Upsala Journal of Medical Sciences|September 21, 2016
Prevention of unintended pregnancy and use of contraception-important factors for preconception careHelena Kopp Kallner, Kristina Gemzell Danielsson
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 17, 2022
Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case reportFarhad Kafi Mallak, Helena Kopp Kallner
Contraception|December 29, 2020
Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortionAnna Egardt, Michael Algovik, Helena Kopp Kallner
Gynecologic and Obstetric Investigation|March 22, 2019
Urodynamics as a Prognosticator of Mirabegron Treatment OutcomesHelena Kopp Kallner, Caroline Elmér, Daniel Altman
American Journal of Obstetrics and Gynecology|May 25, 2024
Mepivacaine instillation for pain reduction during intrauterine device placement in nulliparous women: a double-blinded randomized trialNiklas Envall, Karin Elgemark, Helena Kopp Kallner
Pageof 11